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Biomolecules are susceptible to many different post-translational modifications that have 
important effects on their function and stability, including glycosylation, glycation, 
phosphorylation and oxidation chemistries. Specific conversion of aspartic acid to its 
isoaspartyl derivative or arginine to citrulline leads to autoantibody production in models 
of rheumatoid disease, and ensuing autoantibodies cross-react with native antigens. 
Autoimmune conditions associate with increased activation of immune effector cells and 
production of free radical species via NADPH oxidases and nitric oxide synthases. 
Generation of neo-antigenic determinants by reactive oxygen and nitrogen species ROS 
and RNS) may contribute to epitope spreading in autoimmunity. The oxidation of amino 
acids by peroxynitrite, hypochlorous acid and other reactive oxygen species (ROS) 
increases the antigenicity of DNA, LDL and IgG, generating ligands for which 
autoantibodies show higher avidity. This review focuses on the evidence for ROS and 
RNS in promoting the autoimmune responses observed in diseases rheumatoid arthritis 
(RA) and Systemic Lupus Erythematosus (SLE). It considers the evidence for ROS/RNS-
induced antigenicity arising as a consequence of failure to remove or repair ROS/RNS 
damaged biomolecules and suggests that an associated defect, probably in T cell signal 
processing or/or antigen presentation, is required for development of disease. 
Keywords – reactive oxygen species; reactive nitrogen species; protein oxidation; 
autoantigen; neoantigenic determinant; DNA oxidation 
Take home messages; 
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• Free radical modification of IgG exposes neo-antigenic determinants and 
generates an antigen with higher avidity of interaction with rheumatoid factor than 
native IgG. 
• Free radical modification of DNA exposes neo-antigenic determinants and 
generates an antigen with high avidity of interaction with anti-ds DNA 
autoantibodies than native DNA. 
• Failure to remove/repair modified antigens appear may be important for the 
presentation of neoantigenic determinants to T cells. 
• Absence of autoimmunity in other diseases where autoantibodies are detected e.g. 
cancer suggests that dysfunctional antigen presentation must also be important in 
driving the aberrant inflammatory response.    
 
 4
The phenotype of diffuse autoimmune diseases can be attributed, at least in part, to 
abnormalities of the T cell population with an increased prevalence of CD4+CD28null T 
cells which are neither anergic nor functionally paralyzed [1]. These cells have gained 
proinflammatory capacities and cytotoxic function and are resistant to apoptosis; T cell 
dysfunction is further confounded in autoimmunity by the presence of persistent immune 
complexes arising from the failure of effective antigen removal. Subsequent interaction 
with antibody results in immune complex formation and in turn the complexes bind 
phagocytic cells via Fcγ receptors to facilitate their clearance. Receptor engagement 
triggers a cascade of intracellular pathways in effector cells resulting in production of free 
radicals by the NADPH oxidase on infiltrating neutrophils, monocyte/macrophages and 
resident tissue macrophages with concomitant activation of NFkB and pro-inflammatory 
gene expression [2]. The formation of high levels of the nitrogen-centred free radical, 
nitric oxide, in macrophages via iNOS in humans is debated although recent evidence 
from SLE patients suggests increased nitrite production associated with inflammation [3]. 
The release of myeloperoxidase from neutrophilic granules following activation by 
immune complexes also contributes to the oxidative environment in autoimmune disease 
[4]. Whilst low levels of oxidants have important roles as signalling molecules, over-
production in the absence of adequate antioxidant defence may cause irreversible changes 
to biomolecules and contribute to disease progression. 
Rheumatoid arthritis (RA) has a prevalence of 1:3 of the over-65 population of 
developed countries, with both systemic and localised (within articular joints) 
components. The rheumatoid joint is recognised as a site which undergoes repetitive 
cycles of ischemia and reperfusion and formation of oxygen-derived free radicals [5] with 
the gene expression profile varying according to the degree of hypoxia and re-
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oxygenation. The autoimmune disease, systemic lups erythematosus (SLE), has a strong 
inflammatory component, which is typified by chronic over-production of ROS and RNS 
[6]. 
This review focuses on the current knowledge of the differential roles of acute and 
chronic ROS and RNS production in the generation of neo-antigenic determinants which 
may serve as drivers of T and /or B cell activation with particular focus on SLE and RA. 
Generation of neo-antigenic determinants 
Why antigens which have previously been tolerated may later be seen as foreign 
is the subject of several hypotheses; molecular mimicry has recently been reviewed by 
Blank [7] and is based on the concept that viral or bacterial antigens serve as antigenic 
mimics, i.e., identical to a self protein and, although a normal immune response is 
developed to the pathogen, the resultant antibodies show cross-reactivity towards self-
antigen.  
More recently, epitope spreading has gained credence as a major driver 
underlying autoimmunity (Figure 1). This hypothesis suggests that the development of 
antibodies against other cryptic epitopes on the original antigen, after self-tolerance has 
been broken, provides a mechanism for development of autoantibody production in a 
number of autoimmune diseases including SLE [8]. This model is supported by 
experimental development of autoimmunity in non-autoimmune mice following 
immunisation with self-peptides containing cryptic sites [9]; post-translational 
modification of proteins may elicit an immune response which shows cross-reactivity 
with native peptides.  
Evidence is accumulating for induction of autoimmune responses after a number 
of different post-translational modifications within target proteins [9]; while proteins are 
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normally encoded by variable sequences of 20 amino acids, there are hundreds of 
modified forms of amino acids which may be incorporated into the protein sequence [10]. 
Such modifications can contribute to changes in the backbone [11], alterations in charge 
[12] and differential 3-dimensional folding pattern [13]. Any of these changes may 
generate neo-antigenic determinants, and frequently antibodies raised against peptides 
with minor structural modification can also show cross-reactivity with the native protein, 
thus exhibiting true autoreactivity with self [10]. Neo-antigenic determinants may also 
arise from environmental damage such as UV exposure [14] and as a side effect from 
therapeutic drugs, such as procainamide [14], which can lead to adduct formation with 
self-antigens.  
The detection of autoantibodies against citrullinated proteins, particularly of 
extracellular matrix proteins such as collagen, improves diagnostic specificity for RA 
when compared with rheumatoid factor [15], but there is no clear evidence for increased 
deimination under oxidative stress.   
Another important post-translational modification of proteins is the non-
enzymatic conversion of aspartate to isoaspartic acid [16]. This process occurs 
spontaneously at a low rate, but is enhanced under conditions of stress, exposure to the 
oxidant hydrogen peroxide and with ageing [17]. Mamula et al. [18] reported that 
autoimmune responses characteristic of SLE can be elicited by immunisation with 
isoaspartyl forms of small nuclear (sn) ribonuclear proteins. In addition, Yang et al. [19] 
observed increased intracellular levels of isoaspartyl residues in T cell proteins from SLE 
mice and this has been suggested to contribute to hyperreactivity. Isoaspartyl residues are 
subject to repair by the intracellular repair enzyme, protein isoaspartyl methyl transferase 
(PIMT), which can restore normal aspartyl configuration. PIMT deficient mice express 
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increased levels of anti-DNA antibodies typical of SLE indicating the importance of 
PIMT activity for maintaining immune tolerance [20]. The activity of this enzyme is not 
influenced by ROS despite increased formation of isoaspartyl residues in erythrocytes 
after exposure to hydrogen peroxide [17]. This suggests that damage occurs in excess of 
the capacity to repair, rather than as a deficiency in the repair of post-translational 
modifications may be an important contributor to autoantigen accumulation.  
ROS and RNS levels are increased in autoimmune diseases such as RA and SLE. 
The over-production of  ROS/RNS may exceed the capacity for radical scavenging by 
antioxidant enzymes or small inhibitors and may modify all classes of biomolecules [21] 
therefore generating or exposing neo-antigenic determinants on biomolecules which 
perpetuate antigen driven autoimmune responses [22]. Exposure of proteins to ROS and 
RNS alters their composite amino acids, according to the radical species and the protein 
structure. However, oxidative damage to biomolecules is rarely specific and is dependent 
on the concentration of the protein, its cellular location with respect to cellular oxidant 
generating systems and the rate of modified protein clearance. Increased oxidation of 
LDL also has been reported in RA, with the appearance of foam cell-like structures 
within the rheumatoid synovium [12, 23]. Recent studies have confirmed that vascular 
disease is prevalent in RA, with greater than 50% of RA deaths being attributed to 
cardiovascular disease [24].  
In addition to the prevalent oxidative reactions in RA, Kaur and Halliwell have 
demonstrated a substantial augmentation in tyrosine nitration of plasma proteins is also 
associated with RA [25] and similar observations of elevated 3-nitrotyrosine levels which 
correlated with disease activity were later reported in SLE [26]. A more comprehensive 
analysis of protein oxidation recently has been undertaken in SLE and has shown 
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elevated levels of protein carbonyls, methionine sulphoxide and 3-nitrotyrosine in serum 
proteins with a corresponding reduction in protein thiol content [27] confirming the 
frequency  of post-translational protein  modifications in autoimmunity. 
Although proteins are the most common antigens in autoimmune disease, SLE is 
characterised by the presence of autoantibodies to DNA, and there is mounting evidence 
for enhanced levels of DNA oxidation products, particularly 8-oxodeoxyguanine (8-oxo-
dG), in SLE. Increased levels of oxidation of the base, guanine, to form 8-oxoguanine, is 
observed in the DNA within immune complexes from SLE patients compared with those 
from RA patients [28]. In addition, levels of 8-oxo-dG in the urine of SLE patients are 
significantly reduced [28]. These observations have led to the suggestion that aberrant 
DNA repair in SLE patients contributes to an accumulation of oxidised DNA exposed 
during apoptosis which can form immune complexes and thus perpetuate systemic 
inflammation [28]. 
Modification of antigens by ROS and RNS 
Several authors have shown that IgG is susceptible to oxidative modification 
which may induce aggregation, amino acid modification and/or fragmentation which vary 
according to the denaturing species; hydroxyl radicals cause IgG aggregation, whereas 
peroxy radical species may induce chemical modification in the absence of aggregation 
[29]. In contrast, superoxide anion radicals, in catalytic metal ion free reactions, do not 
cause any biochemical or structural modification. Amino acid analysis has revealed the 
loss of a number of amino acids, which vary according to the denaturing species but 
include tryptophan, methionine and tyrosine. Using reversed phase HPLC, we confirmed 
that tryptophan was converted to N-formyl kynurenine and could be detected in 
rheumatoid serum IgG at higher levels than in serum IgG from age-matched controls 
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[30]. Correspondingly, rheumatoid factor shows higher avidity towards IgG which has 
been modified by OH• than native IgG suggesting that such oxidative modifications 
would perpetuate antigen driven immune responses against IgG [22]. Using UV radiation 
to generate radical on the protein backbone, aggregation and significant loss of 
tryptophan from IgG has been observed.  These changes were shown to correspond with 
changes in IgG isolated from RA patients and an increase in antigenicity of IgG [30].  
In addition to release of simple oxidants, activated neutrophils also release 
myeloperoxidase which catalyses the formation of HOCl from hydrogen peroxide and 
chloride ions. Jasin and colleagues have investigated the effects of HOCl on IgG and 
have demonstrated that formation of mercaptoethanol-resistant, Schiff-base crosslinks 
following the oxidation of lysine residues [4]. Moreover, HOCl or peroxynitrite treatment 
of IgG caused a dose dependent reduction in complement binding and activation, and a 
decrease in binding to Fc receptors on monocytes [31].  The functional changes reported 
above suggest a pro-inflammatory effect, but HOCl modified or nitrated IgGs were found 
to be 20-fold less effective than native IgG in inducing acute inflammation in synovial 
joints, indicating a complex physiological response to IgG chlorination or nitration [32].   
Antibodies against oxidised LDL have been being reported in both SLE and RA 
[33]. Indeed, patients with early RA have elevated auto-antibody titres against oxidised 
LDL compared to healthy controls [34]. Increased levels of autoantibodies towards 
nitrated LDL in RA patients with cardiovascular complications have been observed 
where nitrated LDL was more avidly scavenged by macrophages than native or oxidised 
LDL [35]. The clearance of oxidised or nitrated LDL via scavenger receptors such as 
CD36 present on macrophages may contribute to the incidence of cardiovascular 
complications frequently observed in RA patients.   
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Advanced glycation end-product modifications to proteins are common in 
diabetes, but have also is observed in other conditions such as RA [36]. Correspondingly, 
autoantibodies are observed to AGE-IgG. The mechanisms underlying the frequency of 
this modification in RA are unclear. However, the absence of hyperglycaemia in RA 
patients suggests an accumulation of AGE-modified protein due to failure in degradative 
pathways rather than increased production of AGE as would be expected in diabetes.   
Many of the oxidative modifications of proteins in vitro cause their aggregation, 
thus increasing the valency of a given antigen for antibody. In addition, oxidation causes 
conformational changes including that exposes the hydrophobic regions of proteins, 
increasing their likelihood to bind to other hydrophobic moieties and therefore their 
propensity for degradation [37]; both of these characteristics may explain the increased 
interaction between autoantibodies and autoantigens after oxidation. 
We previously have shown that oxidation of DNA produces an antigen that is 
more discriminating for antibodies present in SLE sera than native DNA and shows 
increased avidity of antibody binding [38]. More recent studies have investigated the 
effects of peroxynitrite on DNA antigenicity; Habib et al. reported that autoantibodies to 
DNA from SLE patients recognised peroxynitrite-modified DNA better than the native 
DNA molecule [39]; these data support the argument that induction of neoantigenic 
determinants in DNA after modification by nitric oxide may  induce high titre 
immunogen-specific antibodies that cross-react with polynucleotides and nucleic acid.  
The oxidation of lipids, particularly polyunsaturated fatty acids, by ROS and RNS 
is widely reported. Lipids exhibit conformational flexibility and thus are only weakly 
antigenic, but their oxidation can lead to the formation of a number of reactive 
intermediates, including 4-hydroxynonenal and malondialdehyde, which may 
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subsequently modify other macromolecules, including proteins via the E-amino group of 
lysine and DNA.  Scofield et al. have demonstrated that 4-hydoxynonenal-mediated 
modification of the lupus-associated 60KDa Ro protein, which associates with RNA, 
increases its antigenicity and facilitates epitope spreading to the nuclear antigens La, 
dsDNA and snRNP [34].  
The foregoing evidence supports the involvement of oxidatively damaged 
biomolecules as antigens which have high avidity for antibodies in the perpetuation of 
autoimmune disease. Indeed, the importance of neo-antigenic determinants in driving 
autoantibody formation is confirmed by the prevalence of elevated levels of 
autoantibodies against DNA, particularly for oxidised DNA [40]. That cancer patients do 
not develop SLE supports the hypothesis that there may be additional aberrations in the 
control of the immune system e.g. in antigen presentation and T cell dysfunction, which 
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Figure 1. Neoantigenic determinant-driven antibody response 
Native peptides do not trigger immune responses. Modification of amino acids by 
reactive oxygen species (ROS) or reactive nitrogen species (RNS) may alter proteolytic 
processing revealing new epitopes which are immunogenic. Antibodies reactive with neo-
antigenic determinants may subsequently cross-react with native antigens in a process 
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